Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice

Davide Loizzo(University of Bari Aldo Moro), Riccardo Autorino(Rush University Medical Center), Ciro Imbimbo(University of Naples Federico II), Georgi Guruli(VCU Massey Comprehensive Cancer Center), Savio Domenico Pandolfo(University of Salerno), Asit K. Paul(Virginia Commonwealth University), Fabio Crocerossa(Magna Graecia University), Giuseppe Lucarelli(University of Bari Aldo Moro), Matteo Ferro(European Institute of Oncology), P. Ditonno(University of Bari Aldo Moro)
European Urology Open Science
March 14, 2022
10.1016/j.euros.2022.02.009
Cited by 49

Related Papers

Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
|Aging|2018|247
Novel Robotic da Vinci Instruments for Laparoendoscopic Single-site Surgery
|Urology|2010|240
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
|Annals of Oncology|2009|205
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
|Biomedicines|2023|161